Caregiver Acceptance of Human Papillomavirus Vaccine for Their Female Children in Chileka, Blantyre, Malawi

Overview

Journal Vaccine X

Date 2024 Oct 9

PMID 39381544

Authors

Akim N Bwanali

Petro Liundi

Adriano F Lubanga

Samuel L Mpinganjira

Luis A Gadama

Affiliations

Soon will be listed here.

Abstract

Introduction: Malawi is one of the countries enduring an enormous burden of cervical cancer. Human Papillomavirus (HPV) vaccination offers a feasible and effective tool for reducing the burden. Such a prospect however, is being impeded by low uptake rates of the HPV vaccine in the country. This study, therefore, sought to identify barriers to caregiver acceptance of the HPV vaccine for their female children in Chileka, Blantyre, Malawi and to establish the consequential willingness to vaccinate their children.

Methodology: A cross-sectional study was conducted using qualitative methods. We conducted 6 Focus Group Discussions (FGDs) with 4 groups of women and 2 groups of men in 4 villages located in a semi-urban area, Chileka, Blantyre. The guiding questionnaire was designed to draw out two main outcomes: barriers to caregiver acceptance of the HPV vaccine and willingness to vaccinate children. The data was analysed by thematic analysis by an inductive approach using NVivo software version 11.

Results: Lack of knowledge on cervical cancer and HPV vaccination coupled with numerous misconceptions are the main barriers discouraging the population from accepting the HPV vaccine. Consequently, there was little desire to get their children vaccinated against HPV. Though responsibility to get the children vaccinated was mainly attributed to women, men argued that they need to have a final say in their children's vaccination.

Conclusion: In the wake of the revealed barriers and low acceptance of the HPV vaccine, it is imperative to organize effective and sustainable awareness programmes for the improvement of the HPV vaccine's uptake.

References

Kiger M, Varpio L . Thematic analysis of qualitative data: AMEE Guide No. 131. Med Teach. 2020; 42(8):846-854. DOI: 10.1080/0142159X.2020.1755030. View

Zhang S, Xu H, Zhang L, Qiao Y . Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2021; 32(6):720-728. PMC: 7797226. DOI: 10.21147/j.issn.1000-9604.2020.06.05. View

Black L, Zimet G, Short M, Sturm L, Rosenthal S . Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine. 2009; 27(11):1668-73. DOI: 10.1016/j.vaccine.2009.01.035. View

Kisaakye E, Namakula J, Kihembo C, Kisakye A, Nsubuga P, Babirye J . Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda. Pan Afr Med J. 2019; 31:184. PMC: 6488240. DOI: 10.11604/pamj.2018.31.184.14801. View

Kutz J, Rausche P, Gheit T, Puradiredja D, Fusco D . Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review. BMC Public Health. 2023; 23(1):974. PMC: 10214362. DOI: 10.1186/s12889-023-15842-1. View

de Martel C, Plummer M, Vignat J, Franceschi S . Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017; 141(4):664-670. PMC: 5520228. DOI: 10.1002/ijc.30716. View

Ports K, Reddy D, Rameshbabu A . Barriers and facilitators to HPV vaccination: perspectives from Malawian women. Women Health. 2013; 53(6):630-45. PMC: 4681389. DOI: 10.1080/03630242.2013.809046. View

Adeyanju G, Sprengholz P, Betsch C, Essoh T . Caregivers' Willingness to Vaccinate Their Children against Childhood Diseases and Human Papillomavirus: A Cross-Sectional Study on Vaccine Hesitancy in Malawi. Vaccines (Basel). 2021; 9(11). PMC: 8623298. DOI: 10.3390/vaccines9111231. View

Athanasiou A, Bowden S, Paraskevaidi M, Fotopoulou C, Martin-Hirsch P, Paraskevaidis E . HPV vaccination and cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2020; 65:109-124. DOI: 10.1016/j.bpobgyn.2020.02.009. View

10.

Brisson M, Kim J, Canfell K, Drolet M, Gingras G, Burger E . Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020; 395(10224):575-590. PMC: 7043009. DOI: 10.1016/S0140-6736(20)30068-4. View

11.

Cubie H, Campbell C . Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi. Womens Health (Lond). 2020; 16:1745506520914804. PMC: 7225784. DOI: 10.1177/1745506520914804. View

12.

Ngcobo N, Jaca A, Iwu-Jaja C, Mavundza E . Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination. Curr Opin Immunol. 2021; 71:21-26. DOI: 10.1016/j.coi.2021.03.006. View

13.

Gerstl S, Lee L, Nesbitt R, Mambula C, Sugianto H, Phiri T . Cervical cancer screening coverage and its related knowledge in southern Malawi. BMC Public Health. 2022; 22(1):295. PMC: 8842862. DOI: 10.1186/s12889-022-12547-9. View

14.

Adeyanju G, Betsch C, Adamu A, Gumbi K, Head M, Aplogan A . Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi. Glob Health Res Policy. 2022; 7(1):28. PMC: 9385415. DOI: 10.1186/s41256-022-00261-3. View

15.

Denny L, Boa R, Williamson A, Allan B, Hardie D, Stan R . Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol. 2008; 111(6):1380-7. DOI: 10.1097/AOG.0b013e3181743327. View

16.

Deignan C, Swartz A, Cooper S, Colvin C . Stakeholders' Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review. Vaccines (Basel). 2021; 9(5). PMC: 8150903. DOI: 10.3390/vaccines9050496. View

17.

Turiho A, Okello E, Muhwezi W, Katahoire A . Perceptions of human papillomavirus vaccination of adolescent schoolgirls in western Uganda and their implications for acceptability of HPV vaccination: a qualitative study. BMC Res Notes. 2017; 10(1):431. PMC: 5577844. DOI: 10.1186/s13104-017-2749-8. View

18.

Ault K . Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol. 2006; 2006 Suppl:40470. PMC: 1581465. DOI: 10.1155/IDOG/2006/40470. View

19.

Kops N, Hohenberger G, Bessel M, Horvath J, Domingues C, Maranhao A . Knowledge about HPV and vaccination among young adult men and women: Results of a national survey. Papillomavirus Res. 2019; 7:123-128. PMC: 6426699. DOI: 10.1016/j.pvr.2019.03.003. View

20.

Bula A, Lee F, Chapola J, Mapanje C, Tsidya M, Thom A . Perceptions of cervical cancer and motivation for screening among women in Rural Lilongwe, Malawi: A qualitative study. PLoS One. 2022; 17(2):e0262590. PMC: 8820632. DOI: 10.1371/journal.pone.0262590. View